• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 11500A
Device Problems Perivalvular Leak (1457); Detachment of Device or Device Component (2907)
Patient Problem Heart Failure/Congestive Heart Failure (4446)
Event Date 09/22/2023
Event Type  Injury  
Manufacturer Narrative
H10: additional manufacturer narrative: the investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
It was learned through implant patient registry and investigation that a 27mm 11500a aortic valve was explanted after an implant duration of 2 years, 3 months due to valve dehiscence and severe large perivalvular leak.The explanted valve was replaced with a 25mm 11060a aortic valved-conduit.Per medical records, the patient presented with acute systolic heart failure secondary to paravalvular aortic insufficiency and underwent a redo avr and redo total aortic root replacement.Intraoperatively the aortic valve had completely separated from the aortic annulus and is free-floating with a large peri-graft hematoma.Essentially previous repair had completely dehisced.There was a huge inflammatory rind around the graft and valve.The tissue around the true aortic annulus was in reasonable condition.Multiple pledgeted sutures were placed in the annulus and a 25mm 11060a aortic valved-conduit was implanted with graft reconstruction of both coronary arteries.Post repair the avc was well-seated with no evidence of periprosthetic insufficiency.The patient was separated from bypass, coagulopathy was extensive as there were multiple areas of inflamed tissue.The patient tolerated the procedure well, after hemostasis was achieved, he was transferred to the cardiovascular recovery unit in serious but stable condition.
 
Manufacturer Narrative
Device dehiscence may occur early or late.When it occurs in the early post-operative period, it is typically a result of inadequate device implantation in combination with friable myocardial tissue.Late dehiscence can occur as a result of successive dilatation of cardiac structures that result from progression of disease.Valve dehiscence is not a malfunction related to a manufacturing deficiency of the device.The root cause of this event was determined to be due to patient related factors, including the patient's friable tissue.The event in this case was impacted by the progression of the patient's underlying valvular disease pathology with nonstructural dysfunction.The subject device is not available for evaluation as it was discarded.The device history record (dhr) review was completed and this device passed all manufacturing and sterilization inspections prior to release for distribution.There were no issues identified that would have impacted this event.There was no allegation of a malfunction which could be related to a manufacturing non-conformance; no labeling non-conformance/deficiency; no use-related issue with a hazardous situation; no device-related infection; and there is no evidence of a product failure with regard to design, reliability, or use error.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INSPIRIS RESILIA AORTIC VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer Contact
saurav singh
1 edwards way
mle fl2 - office m2013
irvine, CA 92614
9492506615
MDR Report Key18186600
MDR Text Key328737835
Report Number2015691-2023-17661
Device Sequence Number1
Product Code DYE
UDI-Device Identifier00690103195002
UDI-Public(01)00690103195002(17)241001(11)201002217191726
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number11500A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/21/2023
Supplement Dates Manufacturer Received12/18/2023
Supplement Dates FDA Received12/27/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/02/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Hospitalization; Required Intervention;
Patient Age48 YR
Patient SexMale
Patient Weight78 KG
-
-